Rosanna Ricafort

Rosanna Ricafort is a prominent pharmaceutical executive and physician currently serving as Vice President, Head of Late Development Hematology and Cell Therapy at Bristol Myers Squibb (BMS).12 Here are some key details about her background and role:

Professional Experience

Rosanna Ricafort has been with Bristol Myers Squibb since 2015, holding increasingly senior leadership positions in Immuno-Oncology Research and Development.1 In her current role, she:

• Leads the company's cell therapy late phase clinical development portfolio
• Drives the implementation of globally aligned clinical development strategies for CAR T therapies
• Is responsible for programs like BREYANZI® (lisocabtagene maraleucel) and ABECMA® (idecabtagene vicleucel)2

Prior to joining BMS, Dr. Ricafort:

• Worked at Celgene supporting the multiple myeloma franchise
• Established and directed the Pediatric Blood and Marrow Transplantation Program at Montefiore Medical Center in New York1

Medical Background

Dr. Ricafort is a pediatric hematologist/oncologist and bone marrow transplant physician by training.1 Her medical education and training include:

• Medical Doctorate from Mount Sinai School of Medicine
• Fellowship in Pediatric Hematology and Oncology at Memorial Sloan-Kettering Cancer Center
• Research fellowship at MSKCC-Sloan Kettering Institute's Department of Human Genetics and Immunology1

Expertise and Contributions

Throughout her career, Dr. Ricafort has:

• Led multiple development programs across solid tumors and hematologic malignancies
• Played a key role in the clinical due diligence for BMS's acquisition of Celgene
• Contributed to successful drug launches and regulatory submissions
• Authored numerous publications and clinical documents23

Dr. Ricafort's expertise spans areas such as immuno-oncology, cell therapy, pediatric oncology, and clinical development strategy.3